VIRUSLI KASALLIKLARGA QARSHI YANGI VAKSINALAR VA ULARNING SAMARADORLIGI.
Keywords:
virusli kasalliklar, vaksina, mRNA vaksina, vektor vaksina, inaktivatsiyalangan vaksina, samaradorlik, virus shtamlari, profilaktika, jamoat sog‘ligi, immunitet.Abstract
Ushbu maqolada virusli kasalliklarga qarshi yangi vaksinalar va ularning samaradorligi tahlil qilinadi. Zamonaviy biotexnologiyalar asosida ishlab chiqilgan vaksinalarning turli turlari — mRNA, vektorli, inaktivatsiyalangan va protein asosidagi vaksinalar ko‘rib chiqiladi. Vaksinalarning samaradorligi, xavfsizligi va virusning yangi shtammlariga qarshi ta’siri haqida so‘nggi ilmiy tadqiqotlar va klinik sinovlar natijalari taqdim etiladi. Shuningdek, vaksinalarning jamoat sog‘lig‘iga ta’siri va keng qamrovli emlash dasturlarining ahamiyati yoritiladi. Maqola virusli infektsiyalarga qarshi samarali profilaktika choralarini ishlab chiqishda innovatsion vaksina texnologiyalarining muhimligini ta’kidlaydi.
References
1. Krammer, F. (2020). SARS-CoV-2 vaccines in development. Nature, 586(7830), 516-527.
2. Pardi, N., Hogan, M.J., Porter, F.W., & Weissman, D. (2018). mRNA vaccines — a new era in vaccinology. Nature Reviews Drug Discovery, 17(4), 261–279.
3. Polack, F.P., et al. (2020). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine, 383(27), 2603-2615.
4. Voysey, M., et al. (2021). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 397(10269), 99-111.
5. World Health Organization (WHO). (2023). COVID-19 vaccine tracker and landscape. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
6. Baden, L.R., et al. (2021). Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of Medicine, 384(5), 403-416.
7. Thanh Le, T., et al. (2020). The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery, 19(5), 305-306.
